CJC-1295 isn't stocked on pharmacy shelves in Aki or most other cities — it's a research compound distributed through a dedicated online market. This matters because CJC-1295 quality ranges widely across the market — from verified research-grade material to material with significant impurity issues — and the vendor determines everything about the product. What genuinely separates top CJC-1295 vendors is comprehensive lot-matched testing data: HPLC for purity, mass spec for molecular identity verification, and endotoxin testing for safety documentation. The sections below cover what Aki researchers need to know about finding, evaluating, and storing CJC-1295 for legitimate research applications.
CJC-1295 Mechanisms Explained
CJC-1295 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Aki studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
How to Source CJC-1295 — Vendor Guide
Quality CJC-1295 sourcing begins with a simple filter: does this vendor share complete COA data without being asked? Vendors who do are operating transparently. The HPLC analytical chromatogram is the most important document in the COA: it should show a clear dominant peak representing CJC-1295, with small or absent impurity peaks representing impurities — purity should be 98% or higher. For Aki researchers evaluating vendors with limited track records: a small initial order to verify quality before placing larger orders is the accepted approach among experienced researchers. Hold lyophilised CJC-1295 at freezer temperature (−20°C) until ready to use; reconstitute only the quantity required for your immediate research and keep the remainder frozen.
Order CJC-1295 — ships to Aki
COA-verified · International tracking · Research grade
All use of CJC-1295 in Aki or anywhere constitutes research use — this compound is not approved for human therapeutic use, and all handling should adhere to research compound handling standards. Lyophilised CJC-1295 should be placed in the freezer at −20°C straight away; repeated freeze-thaw cycles of reconstituted material should be avoided by aliquoting into single-use portions. Quality CJC-1295 sourcing is not separable from research safety — bacterial endotoxin contamination, mislabeling, and degradation products are all safety issues that verified-quality sourcing directly prevents. PubMed represent the most comprehensive research databases for CJC-1295 research; focus on peer-reviewed publications with documented compound quality over conference abstracts or single case observations.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
